April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
CCR3 as a Candidate Target for Presumed Ocular Histoplasmosis Syndrome Diagnosis and Therapy
Author Affiliations & Notes
  • M. J. McConnell
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • J. Z. Baffi
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • H. Kaneko
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • J. C. Pate
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • M. E. Kleinman
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • S. Dridi
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • R. J. C. Albuquerque
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • P. Pearson
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • J. Ambati
    Ophthalmology, University of Kentucky, Lexington, Kentucky
  • Footnotes
    Commercial Relationships  M.J. McConnell, None; J.Z. Baffi, None; H. Kaneko, None; J.C. Pate, None; M.E. Kleinman, None; S. Dridi, None; R.J.C. Albuquerque, None; P. Pearson, None; J. Ambati, Quark, C; Allergan, C; Genentech, C; University of Kentucky, P.
  • Footnotes
    Support  J.B. Physician Scientist Award from University of Kentucky, Heed Ophthalmic Foundation; H.K. None; J.C. P. None; P.A.P. J.A. NEI/NIH, Doris Duke Charitable Fund, Burroughs Wellcome Foundation, RPB
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3351. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. J. McConnell, J. Z. Baffi, H. Kaneko, J. C. Pate, M. E. Kleinman, S. Dridi, R. J. C. Albuquerque, P. Pearson, J. Ambati; CCR3 as a Candidate Target for Presumed Ocular Histoplasmosis Syndrome Diagnosis and Therapy. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3351. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recently we identified CCR3 as a new marker of pathological angiogenesis and as a functional target in neovascular age-related macular degeneration (AMD). The goal of this study is to examine whether choroidal neovascular vessels (CNV) in presumed ocular histoplasmosis syndrome (POHS) also express CCR3. We also studied whether vascular hyperpermeability, a feature of CNV in POHS, was sensitive to CCR3 inhibition.

Methods: : Fibrovascular complexes from patients with POHS were excised by subretinal surgery. The excised subretinal membranes were comprehensively analyzed using histopathology and immunohistochemistry for CCR3 and endothelial cells (CD31). Fluorescein angiography was performed in mice treated with neutralizing anti-CCR3 antibodies versus isotype IgG following laser injury-induced CNV.

Results: : In all (6/6) fibrovascular membranes, CD31 positive endothelial cells expressed CCR3 immunoreactivity. CCR3 neutralization dramatically reduced CNV leakage in the mouse model.

Conclusions: : These data suggest that CCR3 targeting may be a viable strategy for the early detection and treatment of choroidal neovascularization in the setting of POHS.

Keywords: fungal disease • neovascularization • detection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×